Thimerosal Publications and References
Ball L, Ball R, Pratt RD. An assessment of thimerosal in childhood vaccines. Pediatrics. 2001;107:1147–1154.
Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005;113:1015–21.
Hurley AM, Tadrous M, Miller ES. Thimerosal-containing vaccines and autism: A review of recent epidemiologic studies. J Pediatr Pharmacol Ther. 2010 Jul;15(3):173-81.
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003; 290:1763–6.
Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics. 1999;104:568–9.
McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children < 2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008;26(3):427–429.
Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, et al. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines [PDF – 405 KB]. Pediatrics. 2008;121:e208-214.
Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: A descriptive study. Lancet. 2002;360(9347):1737–1741.
Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010 Oct;126(4):656-64.
Stehr-Green P, Tull P, Stellfeld M, Mortenson P, Simpson D: lack of consistent evidence for an association. Autism and Thimerosal-Containing Vaccines: Lack of Consistent Evidence for an Association. Am J Prev Med. 2003 Aug;25(2):101-6.
Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 Years. N Engl J Med. 2007;357:1281-92.
Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases [PDF – 380 KB]. Pediatrics. 2003 Nov;112(5):1039-48.
- Page last reviewed: October 27, 2015
- Page last updated: October 27, 2015
- Content Source: